Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia, and it represents a significant risk factor for the development and progression of kidney disease. This review aims to elucidate the complex interplay between diabetes and kidney disease, highlighting the underlying mechanisms, risk factors, diagnostic approaches, and therapeutic interventions.
Recent reports from various observational investigations revealed and published the outcomes of Non-insulin Anti-diabetic agents. Patients additionally with Type-II Diabetes Mellitus and coronavirus disease, caused by severe acute respiratory syndrome [SARS] has become widespread disease in the world since last 3 years. Age, sex, ethnicity, obesity and co-morbidities all apparently enhance the risk of worst consequences. Glucose lowering drugs and anti-viral drug treatment could limit the risk but impose restrictions on their usage which needs to be carefully assessed. This severe acute respiratory syndrome [coronavirus] might be a potentially triggering and worsen the aspect for the diabetic patients that can bring about severe metabolic complications effecting β-cell function leading to hyperglycaemia and diabetic ketoacidosis.
English
Arabic
Dutch
French
German
Hindi
Italian
Russian
Spanish